Levetiracetam Related Compound A
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

102767-31-7Levetiracetam Related Compound A

● In Stock

Catalogue No.:VL1280012
CAS No.:102767-31-7
Mol. Formula:C₈H₁₅ClN₂O₂
Mol. Weight:206.67

Additional information on CAS 102767-31-7

Parent drug

Levetiracetam

IUPAC Name

(S)-N-(1-Amino-1-oxobutan-2-yl)-4-chlorobutanamide.

Pharmacopoeial Synonyms

N/A

Other Synonyms

(2S)-2-(4-chlorobutanoylamino)butanamide

Smile

O=C(N[C@@H](CC)C(N)=O)CCCCl

InChI

InChI=1S/C8H15ClN2O2/c1-2-6(8(10)13)11-7(12)4-3-5-9/h6H,2-5H2,1H3,(H2,10,13)(H,11,12)/t6-/m0/s1

Description

Levetiracetam Related Compound A is a meticulously characterized reference material that complies with rigorous regulatory requirements, including those defined by USP, EMA, JP, and BP. This product plays a crucial role in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial manufacturing of Levetiracetam. It is further supported by a detailed Structure Elucidation Report (SER), ensuring high accuracy and reliability across a broad range of analytical applications. Levetiracetam is used with other medications to treat seizures. It belongs to a class of drugs known as anticonvulsants.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url